adamantane has been researched along with 2,4-thiazolidinedione in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baron, MA; Dejager, S; Garber, AJ; Rochotte, E; Schweizer, A | 1 |
Bolli, G; Cohen, SE; Dotta, F; Rochotte, E | 1 |
Barnett, AH | 1 |
Banerji, MA; Francis, BH; Purkayastha, D | 1 |
Allen, E; Chen, R; Donovan, M; Fleming, D; Karyekar, C; Ravichandran, S | 1 |
Allen, E; Fleming, D; Frederich, R; Karyekar, CS; Ravichandran, S | 1 |
Allen, E; Bryzinski, B; Cook, W; Frederich, R; Slater, J | 1 |
Bell, KF; Curkendall, SM; Juneau, PL; Thomas, N; Weiss, AJ | 1 |
1 review(s) available for adamantane and 2,4-thiazolidinedione
Article | Year |
---|---|
Translating science into clinical practice: focus on vildagliptin in combination with metformin.
Topics: Adamantane; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Nitriles; Pyrrolidines; Sulfonylurea Compounds; Thiazolidinediones; Vildagliptin | 2009 |
5 trial(s) available for adamantane and 2,4-thiazolidinedione
Article | Year |
---|---|
Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study.
Topics: Adamantane; Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Ligands; Lipids; Male; Middle Aged; Nitriles; Pioglitazone; Proinsulin; Protease Inhibitors; Pyrrolidines; Thiazolidinediones; Treatment Failure; Treatment Outcome; Vildagliptin | 2007 |
Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study.
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Nitriles; Pioglitazone; Pyrrolidines; Thiazolidinediones; Treatment Outcome; Vildagliptin | 2008 |
Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Thiazolidinediones; United States; Young Adult | 2011 |
Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus.
Topics: Adamantane; Aged; Aged, 80 and over; Analysis of Variance; Area Under Curve; Diabetes Mellitus, Type 2; Dipeptides; Double-Blind Method; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Male; Metformin; Thiazolidinediones; Treatment Outcome | 2013 |
Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovascular disease history or cardiovascular risk factors: results of a pooled analysis of phase 3 clinical trials.
Topics: Adamantane; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glyburide; Humans; Hypoglycemic Agents; Metformin; Risk Factors; Thiazolidinediones | 2013 |
2 other study(ies) available for adamantane and 2,4-thiazolidinedione
Article | Year |
---|---|
Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: a retrospective analysis of the GALIANT study.
Topics: Adamantane; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Drug Tolerance; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Kidney Function Tests; Male; Metformin; Middle Aged; Nitriles; Pyrrolidines; Retrospective Studies; Safety; Thiazolidinediones; Vildagliptin | 2010 |
Predictors of medication adherence in patients with type 2 diabetes mellitus.
Topics: Adamantane; Adult; Aged; Databases, Factual; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Models, Biological; Patient Compliance; Sulfonylurea Compounds; Thiazolidinediones | 2013 |